Neither system is definitively “better” across the board, but they excel in very different areas. The UK’s National Health Service delivers universal coverage at roughly half the cost, with longer life expectancy and stronger equity. The US system produces faster access to specialists and higher cancer survival rates, but leaves millions uninsured and spends far more per person. Which system looks better depends entirely on what you value most.
What Each Country Spends
The spending gap is enormous. In 2023, the United States spent $13,432 per person on healthcare, while the United Kingdom spent $6,023. That means the US spends more than double what the UK does per capita, yet consistently ranks lower on international measures of health system performance.
A significant chunk of that extra US spending goes to paperwork rather than patient care. Administrative costs account for about 25.3% of total US hospital expenditures, compared to 15.5% in England. The US system’s mix of private insurers, each with different billing rules and prior authorization requirements, drives much of that overhead. The NHS, funded through general taxation with a single administrative structure, avoids most of that complexity.
Who Lives Longer
People in the UK live longer on average. Life expectancy in the United States is 78.6 years, compared to 81.3 years in England and Wales, a gap of 2.7 years. The difference is even wider for men: 75.9 years in the US versus 79.3 years in England and Wales. For women, the gap narrows to 1.9 years (81.3 vs. 83.2).
A 2024 Johns Hopkins analysis of the latest mortality data found that preventable causes explain nearly all of that gap. Heart disease, drug overdoses, firearm violence, and motor vehicle crashes are the main drivers. These are problems shaped as much by social policy, gun laws, and the opioid crisis as by the healthcare system itself, but they still show up in the final scorecard.
Where the US Wins: Cancer Survival
Cancer care is one area where the US consistently outperforms the UK. Five-year survival rates tell the story clearly. For prostate cancer, the US has a 98% five-year survival rate compared to 87% in the UK. Breast cancer survival is 90% in the US versus 86% in the UK. Colorectal cancer survival runs 65% in the US and 59% in the UK.
Several factors contribute. The US invests heavily in cancer screening programs, and patients with good insurance often get faster access to cutting-edge treatments. The NHS has historically struggled with longer waits between diagnosis and treatment for certain cancers, though it has worked to close that gap in recent years. If you’re diagnosed with cancer and have solid insurance, the US system gives you a measurable survival advantage.
Access and Wait Times
This is the trade-off most people notice. In the US, if you have insurance accepted by a specialist (or can pay out of pocket), you’ll typically wait a few weeks for a non-urgent appointment. In the UK, the path runs through a GP referral, then potentially months waiting for a specialist appointment, then additional months before a procedure actually happens. For urgent and emergency care, both systems respond quickly. The difference is most visible for elective surgeries and non-emergency specialist visits.
The NHS wait time problem has worsened in recent years, with post-pandemic backlogs pushing some patients into waits of over a year for elective procedures. The US avoids this particular bottleneck but creates a different one: people who can’t afford care simply don’t access it at all, which doesn’t show up in wait time statistics but shows up in health outcomes.
Cost to You as a Patient
In the UK, most healthcare is free at the point of use. You pay nothing for a GP visit, hospital stay, or surgery. There are charges for prescriptions in England (currently about £9.90 per item), but prescriptions are free in Scotland, Wales, and Northern Ireland. Dental and eye care have some out-of-pocket costs, but these are capped.
In the US, even with insurance, you face deductibles, copays, and coinsurance that can add up quickly. Average out-of-pocket spending runs about $1,425 per person per year, but that figure masks huge variation. A single emergency room visit or hospitalization can produce bills in the thousands or tens of thousands. Medical debt is a leading cause of personal bankruptcy in the US, a concept that essentially doesn’t exist in the UK.
For someone who is young, healthy, and well-employed with premium insurance, the US system offers fast access and excellent specialist care at a manageable personal cost. For someone who is uninsured, underinsured, or managing a chronic condition on a modest income, the financial exposure can be devastating.
Deaths the Healthcare System Could Prevent
One of the most telling metrics is “amenable mortality,” which tracks deaths from conditions like diabetes, infections, and other diseases that should be survivable with timely medical care. By this measure, both countries have improved over time, but the US lags behind. Between 1999 and 2007, the US amenable mortality rate dropped from 78.2 to 68.8 deaths per 100,000 men under 65. The UK improved faster over the same period, going from 72.7 down to 53.0. The UK started in a worse position and ended up well ahead, suggesting its system has become more effective at catching and treating treatable conditions.
Overall System Rankings
The Commonwealth Fund, which periodically ranks healthcare systems across high-income countries, placed the UK among the top three performers in its 2024 report alongside Australia and the Netherlands. The United States was the clear outlier at the bottom, with “dramatically lower” overall performance. The US ranked poorly on equity, access, and administrative efficiency, while scoring more competitively on the care process itself.
Satisfaction surveys reflect a similar pattern. Only 16% of Americans said their healthcare system needs just minor changes, while 34% said it needs to be completely rebuilt. In the UK, 26% said minor changes were sufficient and 15% wanted a complete rebuild. Neither country’s population is thrilled with its system, but dissatisfaction runs deeper in the US.
What Actually Matters for Your Situation
If you’re comparing these systems because you’re considering a move, or simply trying to understand the debate, here’s what it comes down to. The UK system is designed to ensure that everyone gets decent care regardless of income, and it achieves this at a fraction of the US cost. The trade-offs are longer waits for non-urgent care, lower cancer survival rates, and less choice in providers.
The US system can deliver exceptional care, particularly for complex conditions like cancer, but access depends heavily on your insurance and ability to pay. The best-insured Americans receive some of the finest medical care in the world. The worst-insured receive care that looks more like a middle-income country. The UK’s floor is much higher, while the US ceiling is arguably higher too. The question is whether you judge a healthcare system by its best outcomes or by what it delivers to the average person.